Active Ingredient History

  • Now
Etalocib is a drug candidate that was under development for the treatment of various types of cancer. It acts as a leukotriene B4 receptor antagonist and a PPARγ agonist.   Wikipedia

  • SMILES: CCCc1c(OCCCOc2cc(O)c(cc2CC)c3ccc(F)cc3)cccc1Oc4ccccc4C(=O)O
  • Mol. Mass: 544.62
  • ALogP: 8.05
  • ChEMBL Molecule:
More Chemistry
2-(2-propyl-3-(3-(2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy)propoxy)phenoxy)benzoic acid | etalocib | ly-193111 | ly293111 | ly 293111 | ly-293111 | vml295 | vml-295


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue